Page 4 - Axsm News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Axsm. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Axsm Today - Breaking & Trending Today

Axsome Therapeutics (NASDAQ:AXSM) Given New $125.00 Price Target at Guggenheim

Axsome Therapeutics (NASDAQ:AXSM – Get Free Report) had its price objective lifted by equities researchers at Guggenheim from $110.00 to $125.00 in a research note issued to investors on Wednesday, Benzinga reports. The firm presently has a “buy” rating on the stock. Guggenheim’s target price points to a potential upside of 54.02% from the stock’s […] ....

United States , Piper Sandler , Harbour Investments Inc , Third Bancorp , Axsome Therapeutics Company Profile , Axsome Therapeutics Inc , Fifth Third Bancorp , Tower Research Capital , Royal Bank , Washington Trust Advisors Inc , Axsome Therapeutics , Get Free Report , Trust Advisors , Financial Advisors , Research Capital , Axsome Therapeutics Daily , Nasdaq Axsm , Boost Price Target ,

Axsome Therapeutics (NASDAQ:AXSM) Receives New Coverage from Analysts at UBS Group

UBS Group began coverage on shares of Axsome Therapeutics (NASDAQ:AXSM – Free Report) in a research note published on Tuesday, Marketbeat.com reports. The firm issued a buy rating and a $111.00 price target on the stock. AXSM has been the subject of a number of other research reports. Royal Bank of Canada assumed coverage on […] ....

United States , Piper Sandler , Cantor Fitzgerald , Royal Bank , Sei Investments Co , Raymond James Financial Services Advisors Inc , Jpmorgan Chase Co , Panagora Asset Management Inc , Ubs Group , Axsome Therapeutics Inc , Metlife Investment Management , Axsome Therapeutics , Free Report , Moderate Buy , James Financial Services Advisors , Life Investment Management , Asset Management , Sei Investments , Get Free Report , Axsome Therapeutics Daily , Nasdaq Axsm , Initiated Coverage , Ubs Group Ag ,

Axsome Therapeutics (NASDAQ:AXSM) Sets New 1-Year High at $95.00

Axsome Therapeutics, Inc. (NASDAQ:AXSM – Get Free Report)’s stock price reached a new 52-week high during mid-day trading on Tuesday . The company traded as high as $95.00 and last traded at $94.95, with a volume of 237699 shares traded. The stock had previously closed at $91.50. Analyst Upgrades and Downgrades Several research firms recently […] ....

United States , Piper Sandler , Vanguard Group Inc , Eventide Asset Management , Goldman Sachs Group Inc , Royal Bank , Cantor Fitzgerald , Axsome Therapeutics Inc , Axsome Therapeutics , Get Free Report , Track Capital , Asset Management , Sachs Group , Vanguard Group , Axsome Therapeutics Daily , Nasdaq Axsm ,

Axsome Therapeutics, Inc. (NASDAQ:AXSM) Given Consensus Recommendation of "Moderate Buy" by Brokerages

Shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM – Get Free Report) have been assigned an average rating of “Moderate Buy” from the eleven ratings firms that are currently covering the company, Marketbeat reports. Two equities research analysts have rated the stock with a hold rating and nine have given a buy rating to the company. The […] ....

United States , Piper Sandler , Cantor Fitzgerald , Royal Bank , Axsome Therapeutics Inc , Washington Trust Advisors Inc , Fifth Third Bancorp , Third Bancorp , Tower Research Capital , Axsome Therapeutics Company Profile , Harbour Investments Inc , Axsome Therapeutics , Get Free Report , Trust Advisors , Financial Advisors , Research Capital , Get Free , Axsome Therapeutics Daily , Nasdaq Axsm ,

Axsome Therapeutics, Inc. Expected to Earn FY2023 Earnings of ($4.07) Per Share (NASDAQ:AXSM)

Axsome Therapeutics, Inc. (NASDAQ:AXSM – Free Report) – Equities researchers at Leerink Partnrs raised their FY2023 earnings per share estimates for Axsome Therapeutics in a research note issued on Monday, January 29th. Leerink Partnrs analyst M. Goodman now forecasts that the company will post earnings per share of ($4.07) for the year, up from their […] ....

New York , United States , Piper Sandler , Leerink Partnrs , Investment Management , Axsome Therapeutics Inc , China Universal Asset Management Co , Cantor Fitzgerald , Axsome Therapeutics Company Profile , Phocas Financial Corp , York State Common Retirement Fund , Royal Bank , Axsome Therapeutics , Free Report , Axsome Therapeutic , Get Free Report , China Universal Asset Management , Universal Asset Management , Axsome Therapeutics Daily , Nasdaq Axsm , Earnings Estimates ,